Oxygen Biotherapeutics (OXBT) drops 5.6% after the firm's audit committee discloses ex-Chairman...


Oxygen Biotherapeutics (OXBT) drops 5.6% after the firm's audit committee discloses ex-Chairman & CEO Chris Stern was fired for falsifying his resume, and using his position to effect a transaction that netted him $489K in stock warrants. Oxygen announced Stern's dismassal last month, but didn't provide further details.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs